Phase I Study of JFI447 [68Ga]Ga-DFC413 and Comparison to FFG233 [68Ga]Ga-NNS309 in Patients With Solid Tumors | MicrobiomeTrials← Back to trialsNCT07630961
Phase I Study of JFI447 [68Ga]Ga-DFC413 and Comparison to FFG233 [68Ga]Ga-NNS309 in Patients With Solid Tumors
RecruitingPHASE1INTERVENTIONAL
Trial Details
Start: 2026-06-15Est. Completion: 2028-01-14
Enrollment target: 66 participants Locations- Novartis Investigative Site, Chuo Ku, Tokyo, Japan
Other microbiome trials you might be interested in
CancerPDAC - Pancreatic Ductal AdenocarcinomaNSCLC (Non-small Cell Lung Cancer)CRC (Colorectal Cancer)Advanced Solid Tumors
The purpose of this study is to characterize the safety and tolerability of ALTA3263 in adults with advanced solid tumor…
Orlando, United StatesEst. completion May 2029
Pancreatic Ductal Adenocarcinoma (PDAC)NGS Monitor MRD
Pancreatic ductal adenocarcinoma (PDAC) carries one of the worst prognoses among solid tumors. Even after curative-inten…
Taoyuan, Taiwan
Est. completion Apr 30, 2029